TITLE

Expectorant Action of Bromhexine in Chronic Obstructive Bronchitis

AUTHOR(S)
Hamilton, W. F. D.; Palmer, K. N. V.; Gent, M.
PUB. DATE
August 1970
SOURCE
British Medical Journal;8/1/1970, Vol. 3 Issue 5717, p260
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64097542

 

Related Articles

  • A Rare Cause of Chronic Cough: Plastic Bronchitis. Bayram, Mehmet; Döngel, İsa; Akkoyunlu, Muhammed Emin; Kart, Levent // Respiratory Case Reports;2014, Vol. 3 Issue 2, p101 

    Plastic bronchitis is a rare disease characterized by chronic cough, dyspnea, airway obstruction, and expectorating rubber-like secretions. This entity is mostly seen in children predominantly in association with an underlying congenital heart disease. We present an adult case who was treated...

  • Ambroxol, bromhexine: labelling updates endorsed in EU.  // Reactions Weekly;Mar2015, Vol. 1542 Issue 1, p1 

    An abstract of the article "Ambroxol and bromhexine expectorants: safety information to be updated" is presented.

  • Chronic Obstructive Pulmonary Disease: Beyond Respiratory System. Gupta, Barkha; Kant, Surya; Pant, Neeraj // Internet Journal of Pulmonary Medicine;2008, Vol. 10 Issue 1, p2 

    Chronic obstructive pulmonary disease (COPD) is defined as set of breathing related problems i.e. chronic bronchitis, expectoration and exertional dyspnea characterized by presence of airflow obstruction that is not fully reversible. However, COPD is a preventable and treatable disease with some...

  • Chronic obstructive pulmonary disease and antibiotic use. Smith, Haley // South African Pharmaceutical Journal;2012, Vol. 79 Issue 5, p23 

    Chronic obstructive pulmonary disease (COPD) is a disease state resulting from an abnormal inflammatory response of the lungs to irritant particles and gases, with resultant progressive airflow limitation, that is partially reversible. It is associated with lung hyperinflation and systemic...

  • bronchitis, chronic. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p129 

    An encyclopedia entry for "chronic bronchitis" is presented. It refers to the inflammation of the airways induced by smoking associated with emphysema. It notes that chronic obstructive pulmonary disease is the combination of emphysema and chronic bronchitis. Productive cough and progressive...

  • Progress in Research in Emphysema and Chronic Bronchitis (Book). Kuschner, Marvin // Annals of Internal Medicine;Jan66, Vol. 64 Issue 1, p222 

    Reviews the book 'Progress in Research in Emphysema and Chronic Bronchitis. The Pathogenesis of the Chronic Obstructive Bronchopulmonary Diseases,' edited by Roger S. Mitchell.

  • Chronic Obstructive Pulmonary Disease. Kerstjens, Huib A.; Postma, Dirkje S. // American Family Physician;9/1/2002, Vol. 66 Issue 5, p845 

    Presents information on chronic obstructive pulmonary disease, an airflow obstruction caused by chronic bronchitis or emphysema. Incidence/prevalence; Etiology and risk factors; Prognosis.

  • Visclair.  // Royal Society of Medicine: Medicines;2002, p565 

    This article provides information on Visclair, a proprietary, non-prescription preparation of the mucolytic and expectorant mecysteine hydrochloride from Sinclair. This drug can be used to reduce the viscosity of sputum and thus facilitate expectoration in patients with chronic asthma or...

  • mecysteine hydrochloride.  // Royal Society of Medicine: Medicines;2002, p348 

    This article presents information on mecysteine hydrochloride or methyl cysteine hydrochloride, a drug used to reduce the viscosity of sputum and so acts as an expectorants in patients with disorders of the upper respiratory tract (eg chronic asthma or bronchitis). Administration is oral.

  • Effect of Various Antimicrobial Regimens on the Clinical Course of Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease in Primary Care. Miravitlles, Marc; Llor, Carles; Naberan, Karlos; María Cots, Josep; Molina, Jesús // Clinical Drug Investigation;2004, Vol. 24 Issue 2, p63 

    Aim: To assess whether the empirical administration of different antibiotics for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease (COPD) in the primary-care setting is associated with a different clinical course, principally related to the speed of onset of action....

Share

Other Topics